C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity

Molecular Immunology

Volumn 46, Issue 5, 2009, Pages 991-998

  Kamal, Maud ^a,b   Valanciute, Asta ^a,b   Dahan, Karine ^a,b   Ory, Virginie ^a,b   Pawlak, Andre ^a,b   Lang, P ^a,b,c,d   Guellaen, Georges ^a,b   Sahali, Djillali ^a,b,c,d  

^a INSERM   (France)

^b INSERM U955   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

C mip; NF B; RelA; T cell signaling

Indexed keywords

C MAF INDUCING PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; LEUCINE; PLECKSTRIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISSOCIATION; EMBRYO; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 59249088848     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.09.034     Document Type: Article

References (15)

1. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995) 167-170
2. Gajewski T.F., Schell S.R., Nau G., and Fitch F.W. Regulation of T-cell activation: differences among T-cell subsets. Immunol. Rev. 111 (1989) 79-110
3. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-96
4. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
5. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
6. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
7. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000) 86-90
8. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
9. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
10. Li Q., Van Antwerp D., Mercurio F., Lee K.F., and Verma I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284 (1999) 321-325
11. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., and Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189 (1999) 1839-1845
12. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6 (2005) 777-784
13. Sahali D., Pawlak A., Le Gouvello S., Lang P., Valanciute A., Remy P., Loirat C., Niaudet P., Bensman A., and Guellaen G. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J. Am. Soc. Nephrol. 12 (2001) 1648-1658
14. Sahali D., Pawlak A., Valanciute A., Grimbert P., Lang P., Remy P., Bensman A., and Guellen G. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J. Am. Soc. Nephrol. 13 (2002) 1238-1247
15. Shan X., Czar M.J., Bunnell S.C., Liu P., Liu Y., Schwartzberg P.L., and Wange R.L. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20 (2000) 6945-6957